consciousness research, David Pearce, Effective Altruism, Harm Reduction, Hedonic Tone, psychedelic, valence

DMT for Cluster Headaches: Aborting and Preventing Extreme Pain with Tryptamines and Other Methods

Posted on by algekalipso

“If we lived in a really sane society with a strong compassionate streak, every building would have something like a ‘Break in case of fire’ box… only this one would read ‘Break in case of cluster headache.’ Inside you’d find a pre‑charged DMT vape pen. That would be really nice.”

Announcement: Do you have experience using psychedelics to treat cluster headaches? Want to support science and advocacy in this area? Submit your personal and/or professional testimonial to our upcoming “ClusterFree” Open Letter initiative.

Sitting Down with Cluster Busters at Psychedelic Science 2025

One of the highlight moments for me at Psychedelic Science 2025 in Denver this June was conducting an interview for Bob Wold, founder of Cluster Busters, and Joe Stone, and Joe McKay who work alongside Bob in patient support and advocacy.  Our conversation covered a lot of ground, but I had one key strategic goal in mind: document, in their own words, why the humble DMT vape pen looks like a once‑in‑a‑generation breakthrough for the most painful condition that medicine has ever encountered.

“With a regular vape pen it’s usually one inhalation. Thirty seconds later the pain is gone. I hear a click in the middle of my brain and the attack is just off.” —Bob Wold

Their story plugs directly into QRI’s ongoing attempt to map the upper reaches of experience (QRI has the long-standing mission of mapping the state-space of consciousness, reverse engineer valence, and reduce suffering at scale). Our logarithmic scales of pleasure and pain shows that as one climbs up the pain (or pleasure) scales, phenomenal intensity rises far higher than common sense anticipates. The Heavy‑Tailed Valence hypothesis extends that insight to society at large and seeks to question the validity of current econometric approaches to collective wellbeing (cf. QALYs) in light of the fact that the extremes are not properly represented. From where we stand, it seems that a handful of wildly intense states do most of the moral damage (or good). Cluster headaches live in that fat tail, which is precisely why a 30‑second fix like DMT matters so much; perhaps as big of a collective hedonic breakthrough as, say, the discovery of anesthesia (in aggregate).

Put bluntly, if we care about total suffering, we need to care about cluster headaches. The time is now.

Interview Highlights Pertaining to DMT

  • DMT as an acute rescue
    One lungful (where the instructions typically say “three full breaths”) ends most attacks in under a minute. A second puff a minute later covers nearly all the rest. No tolerance shows up (acutely or chronically) which allows patients to repeat the dose whenever necessary.
  • Low psychedelic burden
    The dose is about a quarter of a psychedelic hit; enough to see some color enhancement but not enough for significant “trippiness”. Patients describe “a mild two‑beer buzz” or “the room takes on a golden tint” or “faint auras appear.” The mild level of psychedelia needed for this treatment makes bedside use practical, even for parents who need to stay functional the day after.
  • Why it beats psilocybin and LSD in the heat of battle
    Psilocybin and LSD still shine for cycle prevention, taken every five days, but they work on a timescale that makes them impractical for acute events. DMT is for the here‑and‑now (note Eleusinia founder says DMT also interrupt cycles according to her work at the retreat center). Joe Stone calls it “a game changer” because he can abort a 2AM ethical emergency (a cluster) and fall back asleep within 10 minutes. No need to have an expensive psychotherapy, a professional sitter, or trip killers on hand, let alone having to book a whole day to trip.
  • A hunch about endogenous DMT
    Bob’s shares his intuitive working model for how cluster headaches work (to be refuted or confirmed by science): an attack begins when natural DMT in the brain dips below a threshold (why do we even have DMT in our brains to begin with?). He hazards the guess that a quick DMT top‑up pulls the breaks and re‑establishes homeostasis. Others suggest that melatonin abnormalities in cluster patients add plausibility to his view, given the biochemical link between melatonin and endogenous tryptamine synthesis.
  • Pain drives the psychiatric condition, not the other way around
    One key insight I wanted to make sure to get on the record: chronic physical agony breeds depression, anxiety, and PTSD‑like flashbacks. Fix the pain and the mental distress often dissolves; no need for heroic doses or eight‑hour therapy sessions (as with e.g. psilocybin for depression specifically). Cultural over-emphasis on mental health as _the_ thing to treat with psychedelics might make sense from the point of view of a slowly expanding Overton Window; but the big hedonic payouts (freedom from hellish states of consciousness) are likely concentrated in their application to the reduction of extreme physical pain (see also).

Why This Matters

Alfredo Parra’s quantitative analysis suggests that cluster headaches may contribute more net misery than migraines, cancer pain, or even major depressive disorder once intensity is included (and a proper long-tail model and Monte Carlo simulations are taken into accont). Effective Altruist “pleasure-bean‑counters” (I say this affectionately!) please take note: extremely nasty but “rare” states can dominate the integral, and need urgent consideration.

From a consciousness‑research angle, the interview is another data point for why direct phenomenological investigation should guide ethics; here, patients, confronted with the reality of their own phenomenology, themselves have again clearly pioneered the treatment all the while mainstream research (unsurprisingly) slept through five decades of drug war.

Closing Thoughts

Imagine a fire‑alarm box on every hospital wall that reads “Break glass in case of cluster headache.” Inside we find a sober-looking, very boring but perfectly functional, pre‑filled DMT cartridge that delivers reliable 3mg hits (enough to feel a light buzz, not enough to trip significantly – certainly far short of any dose needed for entity contact or alien abduction experiences). This isn’t science fiction; it is what the data we’re seeing support.  Freedom from one of the most extreme demonic forces on Earth is, counterintuitively… Spice. Let’s shorten the path from patient innovation to standard‑of‑care and, in the process, erase one of the darkest corners of conscious experience forever. I believe we can achieve a Cluster-Free World within a few years if we put our minds and hearts to the task.

Hallucinations are not a problem at the doses we have people use and that seem to work the best, which are much smaller than a recreational dose. We aren’t recommending people take doses that will have them playing cards with a deer (you can’t trust them!). The doses are small (e.g. 1.5g of mushrooms). You’re supposed to get to about the “giggle”. Get to the “giggle point” and you’re good to go. – Suicide or Psychedelics, Bob Wold at Horizons 2009

Resources and Further Reading:

How You Can Contribute:

  • Donate to Cluster Busters
  • Donate to QRI (earmark for “Cluster Headache Research and Advocacy”)
  • Donate to OPIS (Organization for the Prevention of Intense Suffering)
  • Share your testimonial if you’ve experienced relief through psychedelic therapy: Submit Here

Stay tuned for QRI’s upcoming Open Letter advocating for psychedelic access in treating severe pain conditions, the ClusterFree worldwide initiative.

Leave a Reply